These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27838588)

  • 21. Effects of Long-Term Alcohol Drinking on the Dopamine D2 Receptor: Gene Expression and Heteroreceptor Complexes in the Striatum in Rats.
    Feltmann K; Borroto-Escuela DO; Rüegg J; Pinton L; de Oliveira Sergio T; Narváez M; Jimenez-Beristain A; Ekström TJ; Fuxe K; Steensland P
    Alcohol Clin Exp Res; 2018 Feb; 42(2):338-351. PubMed ID: 29205397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.
    Fuxe K; Guidolin D; Agnati LF; Borroto-Escuela DO
    Expert Opin Ther Targets; 2015 Mar; 19(3):377-98. PubMed ID: 25486101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex.
    Casadó-Anguera V; Bonaventura J; Moreno E; Navarro G; Cortés A; Ferré S; Casadó V
    Biochem Soc Trans; 2016 Apr; 44(2):595-600. PubMed ID: 27068975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic-Like Efficacy of Dopamine D
    Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V
    Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis.
    Fuxe K; Marcellino D; Leo G; Agnati LF
    Curr Opin Pharmacol; 2010 Feb; 10(1):14-22. PubMed ID: 19942481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
    Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
    Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the Interface of a GPCR Dimer: A Structural Model of the A
    Borroto-Escuela DO; Rodriguez D; Romero-Fernandez W; Kapla J; Jaiteh M; Ranganathan A; Lazarova T; Fuxe K; Carlsson J
    Front Pharmacol; 2018; 9():829. PubMed ID: 30214407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Balance of MU-Opioid, Dopamine D2 and Adenosine A2A Heteroreceptor Complexes in the Ventral Striatal-Pallidal GABA Antireward Neurons May Have a Significant Role in Morphine and Cocaine Use Disorders.
    Borroto-Escuela DO; Wydra K; Fores-Pons R; Vasudevan L; Romero-Fernandez W; Frankowska M; Ferraro L; Beggiato S; Crespo-Ramirez M; Rivera A; Rocha LL; Perez de la Mora M; Stove C; Filip M; Fuxe K
    Front Pharmacol; 2021; 12():627032. PubMed ID: 33790790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute Cocaine Enhances Dopamine D
    Borroto-Escuela DO; Narváez M; Romero-Fernández W; Pinton L; Wydra K; Filip M; Beggiato S; Tanganelli S; Ferraro L; Fuxe K
    Mol Neurobiol; 2019 Oct; 56(10):7045-7055. PubMed ID: 30972626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation.
    Borroto-Escuela DO; Hinz S; Navarro G; Franco R; Müller CE; Fuxe K
    Front Neurosci; 2018; 12():43. PubMed ID: 29467608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OSU-6162, a Sigma1R Ligand in Low Doses, Can Further Increase the Effects of Cocaine Self-Administration on Accumbal D2R Heteroreceptor Complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Wydra K; Zhou Z; Suder A; Filip M; Fuxe K
    Neurotox Res; 2020 Feb; 37(2):433-444. PubMed ID: 31782100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson's disease and its treatment.
    Borroto-Escuela DO; Fuxe K
    J Neural Transm (Vienna); 2019 Apr; 126(4):455-471. PubMed ID: 30637481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oxytocin receptor represents a key hub in the GPCR heteroreceptor network: potential relevance for brain and behavior.
    Borroto-Escuela DO; Cuesta-Marti C; Lopez-Salas A; Chruścicka-Smaga B; Crespo-Ramírez M; Tesoro-Cruz E; Palacios-Lagunas DA; Perez de la Mora M; Schellekens H; Fuxe K
    Front Mol Neurosci; 2022; 15():1055344. PubMed ID: 36618821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the role of heteroreceptor complexes in the central nervous system.
    Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
    Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment with Sigma1R and A2AR agonists fails to inhibit cocaine self-administration despite causing strong antagonistic accumbal A2AR-D2R complex interactions: the potential role of astrocytes.
    Borroto-Escuela DO; Lopez-Salas A; Wydra K; Bartolini M; Zhou Z; Frankowska M; Suder A; Benitez-Porres J; Romero-Fernandez W; Filip M; Fuxe K
    Front Mol Neurosci; 2023; 16():1106765. PubMed ID: 37293542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A
    Ferré S; Bonaventura J; Zhu W; Hatcher-Solis C; Taura J; Quiroz C; Cai NS; Moreno E; Casadó-Anguera V; Kravitz AV; Thompson KR; Tomasi DG; Navarro G; Cordomí A; Pardo L; Lluís C; Dessauer CW; Volkow ND; Casadó V; Ciruela F; Logothetis DE; Zwilling D
    Front Pharmacol; 2018; 9():243. PubMed ID: 29686613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.
    Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A
    Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.
    Canals M; Marcellino D; Fanelli F; Ciruela F; de Benedetti P; Goldberg SR; Neve K; Fuxe K; Agnati LF; Woods AS; Ferré S; Lluis C; Bouvier M; Franco R
    J Biol Chem; 2003 Nov; 278(47):46741-9. PubMed ID: 12933819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.